- ACTIVE INGREDIENT
- INACTIVE INGREDIENT
- PURPOSE
- KEEP OUT OF REACH OF CHILDREN
- INDICATIONS & USAGE
-
WARNINGS
[DO NOT USE]
if you are hypersensitive to this drug and any component of this drug
if you have a history of asthma after taking this drug, other cold drugs or antipyreticanalgesics
in infants under 3 months of age
if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for
depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after
stopping the MAOI drug
with antitussive expectorants, other cold medicines, antipyretic-analgesics, sedatives,
antihistamines(certain drugs for rhinitis, preventive drugs for travel sickness, allergies)
[ASK A DOCTOR OR PHARMACIST BEFORE USE]
in infants or children under 15 years infected with chickenpox or influenza
in infants under 2 years of age only when it is necessary. Inform to the guardian/s and
monitor closely while administering
if you are genetically prone to uticaria, contact dermatitis, bronchial asthma, allergic rhinitis,
migraine, food allergy
If you have allergic reactions (e.g., fever, rash, arthralgia, asthma, itch, etc.) to this drug and
any component of this drug
if you have liver disease, kidney disease, heart disease, thyroid disease, diabetes, high blood
pressure, edema, stomach-duodenal ulcer, glaucoma, dysuria, high fever
if you are elderly or week
if you have bleeding , ache and discomfort in stomach
If (possibly) pregnant or breast-feeding
If you are taking a prescription drug for diabetes, goat, arthritis, anticoagulants and steroids
if you have cough by smoking, asthma, chronic bronchitis, emphysema, cough accompanied
with excessive sputum, fever, rash, persistent headache and cough lasting more than 1 week,
recurrent cough or chronic cough
[STOP USE AND ASK A DOCTOR IF]
you experience any of the following symptoms:
rash, redness, itching, nausea, vomiting, loss of appetite, constipation, edema, dysuria, severe
or persistent thirst, dizziness, anxiety, shivering, insomnia
you experience any of the following severe symptoms:
anaphylaxis (e.g., immediate rash, edema, shortness of breath along with paling of face,
cold sweat, cold hands and feet)
Stevens-Johnson syndrome (mucocutaneous syndrome) or Lyell syndrome (toxic epidermal
necrosis) (e.g., rash and redness accompanied with high fever, blisters as in burn over the
body or mucous membranes of mouth or eyes) asthma
liver dysfunction (e.g., drowsiness, jaundice)
interstitial pneumonia (e.g., shortness of breath, fever accompanied with cough)
aldosteronism: long-term continuous use of preparations containing over than 1g as licorice
(daily maximum dose) may cause hypokalemia, increased blood pressure, fluid retention of
sodium, edema, weight gain, aldosteronism. Observe closely (blood potassium concentration)
and stop taking this drug and when you have above symptoms.
myopathy may rarely occur as a result of hypokalemia. Observe closely and stop taking this
drug when you appear symptoms such as weakness, limb spasms, and numbness.
[WHEN USING THIS PRODUCT]
do not exceed recommended dosage
do not take for a long period of time
administer to children under the guidance and supervision of a guardian
avoid alcoholic drinks
do not drive a motor vehicle or operate machinery
barbiturates, tricyclic antidepressants, and alcohol may reduce the ability to metabolize large
quantities of acetaminophen, thereby increasing the plasma half-life of acetaminophen
myopathy may occur due to aldosteronism or hypokalemia when administered with drugs
containing potassium, licorice, glycyrrhizin acid or its salts, loop diuretics (furosemide,
ethacrynic acid) or thiazide diuretic (trichlormethiazide). - DOSAGE & ADMINISTRATION
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
HABEN HERB
chlorpheniramine maleate capsuleProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:69195-1001 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CHLORPHENIRAMINE MALEATE (UNII: V1Q0O9OJ9Z) (CHLORPHENIRAMINE - UNII:3U6IO1965U) CHLORPHENIRAMINE MALEATE 1.25 mg Inactive Ingredients Ingredient Name Strength POVIDONE (UNII: FZ989GH94E) MAGNESIUM STEARATE (UNII: 70097M6I30) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) Product Characteristics Color yellow (Haben Herb) Score 2 pieces Shape CAPSULE (Haben Herb) Size 20mm Flavor Imprint Code 3;hp;x Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:69195-1001-1 10 in 1 PACKAGE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part341 08/27/2014 Labeler - Beverly Hills Holdings Co,. Ltd. (689061741) Registrant - Beverly Hills Holdings Co,. Ltd. (689061741) Establishment Name Address ID/FEI Business Operations Korean Drug Co., Ltd. 689276249 manufacture(69195-1001)